SCHEMBL30429249

SCHEMBL30429249

CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 8/20 0.65
▸ NPY4R P50391 8/20 0.65
▸ NPY5R Q15761 8/20 0.65
▸ NPY1R P25929 6/20 0.65
▸ RAMP3 O60896 1/20 0.63
▸ CALCR P30988 1/20 0.63
▸ KDM1A O60341 3/20 0.62
▸ TFPI P10646 4/20 0.60
▸ EPHA2 P29317 2/20 0.59
▸ MAOB P27338 1/20 0.59
▸ KDM5A P29375 1/20 0.59
▸ KDM1B Q8NB78 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396082 0.93 RAMP3 (0.64) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL31182494 0.92 NPY2R (0.69) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30176462 0.90 NPY2R (0.68) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL31027702 0.90 EPHA2 (0.65) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30495735 0.90 RAMP3 (0.67) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL29396808 0.89 RAMP3 (0.60) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30834205 0.89 NPY2R (0.66) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30495690 0.89 NPY2R (0.68) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL31174223 0.87 NPY2R (0.64) NPY2RNPY4RNPY5RNPY1RRAMP3
SCHEMBL30262082 0.87 RAMP3 (0.65) NPY2RNPY4RNPY5RNPY1RRAMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback